Prevalence of TMC278 (rilpivirine) associated mutations in the Frankfurt Resistance DatabaseREINHEIMER, Claudia; DOERR, Hans W; STURMER, Martin et al.Journal of clinical virology. 2012, Vol 53, Num 3, pp 248-250, issn 1386-6532, 3 p.Article

Pre-existing mutations in the rilpivirine Phase III trials ECHO and THRIVE: prevalence and impact on virological responseVINGERHOETS, Johan; RIMSKY, Laurence; VAN EYGEN, Veerle et al.Antiviral therapy (London). 2013, Vol 18, Num 2, pp 253-256, issn 1359-6535, 4 p.Article

Lack of Pharmacokinetic Interaction between Rilpivirine and Integrase Inhibitors Dolutegravir and GSK1265744FORD, Susan L; GOULD, Elizabeth; SHUGUANG CHEN et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 11, pp 5472-5477, issn 0066-4804, 6 p.Article

Rilpivirine Inhibits Drug Transporters ABCB1, SLC22A1, and SLC22A2 In VitroMOSS, Darren M; LIPTROTT, Neill J; CURLEY, Paul et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 11, pp 5612-5618, issn 0066-4804, 7 p.Article

Skeletal muscle toxicity associated with emtricitabine/rilpivirine/tenofovir fixed-dose combination: a case reportLIEM BINH LUONG NGUYEN; HARENT, Stanislas; PEYTAVIN, Gilles et al.AIDS (London). 2014, Vol 28, Num 13, pp 1995-1997, issn 0269-9370, 3 p.Article

Dead-end complexes contribute to the synergistic inhibition of HIV-1 RT by the combination of rilpivirine, emtricitabine, and tenofovirKULKARNI, Rima; FENG, Joy Y; MILLER, Michael D et al.Antiviral research. 2014, Vol 101, pp 131-135, issn 0166-3542, 5 p.Article

Distinct resistance patterns to etravirine and rilpivirine in viruses containing nonnucleoside reverse transcriptase inhibitor mutations at baselineASAHCHOP, Eugene L; WAINBERG, Mark A; OLIVEIRA, Maureen et al.AIDS (London). 2013, Vol 27, Num 6, pp 879-887, issn 0269-9370, 9 p.Article

Naturally Selected Rilpivirine-Resistant HIV-1 Variants by Host Cellular ImmunityGATANAGA, Hiroyuki; MURAKOSHI, Hayato; HACHIYA, Atsuko et al.Clinical infectious diseases. 2013, Vol 57, Num 7, pp 1051-1055, issn 1058-4838, 5 p.Article

Rilpivirine vs. efavirenz in HIV-1 patients with baseline viral load 100 000 copies/ml or less: week 48 phase III analysisMOLINA, Jean-Michel; CLUMECK, Nathan; PEDANT, Karla et al.AIDS (London). 2013, Vol 27, Num 6, pp 889-897, issn 0269-9370, 9 p.Article

Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989-2009)DE BETHUNE, Marie-Pierre.Antiviral research. 2010, Vol 85, Num 1, pp 75-90, issn 0166-3542, 16 p.Article

Résistance aux nouveaux antirétroviraux = HIV-1 resistance to new antiretroviral drugsDELAUGERRE, Constance.La Lettre de l'infectiologue. 2008, Vol 23, Num 5, pp 169-174, issn 0296-9009, 6 p.Article

E138A in HIV-1 reverse transcriptase is more common in subtype C than B: Implications for rilpivirine use in resource-limited settingsSLUIS-CREMER, Nicolas; JORDAN, Michael R; HUBER, Kelly et al.Antiviral research. 2014, Vol 107, pp 31-34, issn 0166-3542, 4 p.Article

Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participantsPALELLA, Frank J; FISHER, Martin; WHITE, Kirsten et al.AIDS (London). 2014, Vol 28, Num 3, pp 335-344, issn 0269-9370, 10 p.Article

Edurant (rilpivirine), inhibiteur non nucléosidique de la transcriptase inverse = Rilpivirine: less powerfull but a better tolerance than efavirenzLE DU, Damien.La Revue du praticien (Paris). 2013, Vol 63, Num JAN, issn 0035-2640, S3-S5, SUPArticle

E138K and M1841 mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposureFOURATI, Slim; MALET, Isabelle; CALVEZ, Vincent et al.AIDS (London). 2012, Vol 26, Num 13, pp 1619-1624, issn 0269-9370, 6 p.Article

rilpivirine ^(EDURANT°): En première ligne contre le HIV: l'éfavirenz est mieux connuLa Revue Prescrire. 2012, Vol 32, Num 345, pp 494-497, issn 0247-7750, 4 p.Article

Role of Non-Nucleoside Reverse Transcriptase Inhibitors in Treating HIV-Infected ChildrenPENAZZATO, Martina; GIAQUINTO, Carlo.Drugs (Basel). 2011, Vol 71, Num 16, pp 2131-2149, issn 0012-6667, 19 p.Article

The outlook for a cure : HIV/AIDSHUGHES, Virginia.Nature (London). 2010, Vol 466, Num 7304, issn 0028-0836, S11-S13Article

Etravirine and Rilpivirine : Nonnucleoside Reverse Transcriptase Inhibitors with Activity Against Human Immunodeficiency Virus Type 1 Strains Resistant to Previous Nonnucleoside AgentsPECORA FULCO, Patricia; MCNICHOLL, Lan R.Pharmacotherapy. 2009, Vol 29, Num 3, pp 281-294, issn 0277-0008, 14 p.Article

Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase and Their Interactions with the M184I Mutation on Defining Patterns of Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Rilpivirine and EtravirineXU, Hong-Tao; COLBY-GERMINARIO, Susan P; ASAHCHOP, Eugene L et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 7, pp 3100-3109, issn 0066-4804, 10 p.Article

Human Biotransformation of the Nonnucleoside Reverse Transcriptase Inhibitor Rilpivirine and a Cross-Species Metabolism ComparisonLADE, Julie M; AVERY, Lindsay B; BUMPUS, Namandjé N et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 10, pp 5067-5079, issn 0066-4804, 13 p.Article

Role of the K101E Substitution in HIV-1 Reverse Transcriptase in Resistance to Rilpivirine and Other Nonnucleoside Reverse Transcriptase InhibitorsXU, Hong-Tao; COLBY-GERMINARIO, Susan P; WEI HUANG et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 11, pp 5649-5657, issn 0066-4804, 9 p.Article

LC Assay for a HIV Tablet Containing Emtricitabine, Tenofovir Disoproxil Fumarate and RilpivirinePENDELA, Murali; WELDU KAHSAY, Getu; VAN DEN MOOTER, Guy et al.Chromatographia (Wiesbaden). 2011, Vol 73, Num 5-6, pp 439-445, issn 0009-5893, 7 p.Article

Recent Advances in DAPYs and Related Analogues as HIV-1 NNRTIsXUWANG CHEN; PENG ZHAN; DONGYUE LI et al.Current medicinal chemistry. 2011, Vol 18, Num 3, pp 359-376, issn 0929-8673, 18 p.Article

Nonnucleoside Reverse Transcriptase Inhibitor Resistance and the Role of the Second-Generation AgentsADAMS, Jessica; PATEL, Nimish; MANKARYOUS, Nancy et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 1, pp 157-165, issn 1060-0280, 9 p.Article